标题
Terapias emergentes en el tratamiento médico de los miomas uterinos
作者
关键词
-
出版物
MEDICINA CLINICA
Volume 161, Issue -, Pages S32-S37
出版商
Elsevier BV
发表日期
2023-11-01
DOI
10.1016/j.medcli.2023.06.034
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Systematic review of oral pharmacotherapeutic options for the management of uterine fibroids
- (2022) Richard J. Rovelli et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis
- (2022) Juliawati Muhammad et al. BMC Womens Health
- Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids
- (2022) Giulio Evangelisti et al. Expert Opinion on Drug Metabolism & Toxicology
- Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials
- (2022) Jacques Donnez et al. LANCET
- Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy
- (2021) Ayman Al-Hendy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas
- (2021) Susan Dababou et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview
- (2021) Marcus-Hillert Schultze-Mosgau et al. CLINICAL PHARMACOKINETICS
- Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids
- (2020) William D. Schlaff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding—delayed add-back onset does not improve bleeding pattern
- (2020) Oliver Pohl et al. Reproductive Sciences
- Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2
- (2020) Kristina Gemzell-Danielsson et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis
- (2020) Olivier Donnez et al. FERTILITY AND STERILITY
- Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
- (2020) James A. Simon et al. OBSTETRICS AND GYNECOLOGY
- Hormone therapy for intramural myoma-related infertility from ulipristal acetate to GnRH antagonist: a review
- (2020) Donnez Jacques et al. REPRODUCTIVE BIOMEDICINE ONLINE
- LIBERTY: LONG-TERM EXTENSION STUDY DEMONSTRATING ONE-YEAR EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS
- (2020) Ayman Al-Hendy et al. FERTILITY AND STERILITY
- Fibroids and medical therapy: bridging the gap from selective progesterone receptor modulators to gonadotropin-releasing hormone antagonist
- (2020) Jacques Donnez et al. FERTILITY AND STERILITY
- Uterine fibroids: an update on current and emerging medical treatment options
- (2019) Manuela Farris et al. Therapeutics and Clinical Risk Management
- Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas
- (2019) Yutaka Osuga et al. OBSTETRICS AND GYNECOLOGY
- Relugolix: First Global Approval
- (2019) Anthony Markham DRUGS
- Liver injury and ulipristal acetate: an overstated tragedy?
- (2018) Jacques Donnez FERTILITY AND STERILITY
- Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study
- (2018) Linda D. Bradley et al. FERTILITY AND STERILITY
- Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
- (2018) Bruce R. Carr et al. OBSTETRICS AND GYNECOLOGY
- Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study
- (2017) David F. Archer et al. FERTILITY AND STERILITY
- Therapeutic outcomes of the LHRH antagonists
- (2017) Athanasios Dellis et al. Expert Review of Pharmacoeconomics & Outcomes Research
- The medical management of abnormal uterine bleeding in reproductive-aged women
- (2016) Linda D. Bradley et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women
- (2016) Barbara Schütt et al. HUMAN REPRODUCTION
- Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids
- (2015) Jacques Donnez et al. FERTILITY AND STERILITY
- The impact of uterine leiomyomas: a national survey of affected women
- (2013) Bijan J. Borah et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery
- (2012) Jacques Donnez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety
- (2011) Philippe Bouchard et al. FERTILITY AND STERILITY
- Fibroids and infertility: an updated systematic review of the evidence
- (2008) Elizabeth A. Pritts et al. FERTILITY AND STERILITY
- Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix
- (2008) R. Scott Struthers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now